Coronavirus disease 2019 (COVID-19) is a highly contagious disease and a serious threat to human health. COVID-19 can cause multiple organ dysfunction, such as respiratory and circulatory failure, liver and kidney injury, disseminated intravascular coagulation, and thromboembolism, and even death. The World Health Organization reports that the mortality rate of severe-type COVID-19 is over 50%. Currently, the number of severe cases worldwide has increased rapidly, but the experience in the treatment of infected patients is still limited. Given the lack of specific antiviral drugs, multi-organ function support treatment is important for patients with COVID-19. To improve the cure rate and reduce the mortality of patients with severe- and critical-type COVID-19, this paper summarizes the experience of organ function support in patients with severe- and critical-type COVID-19 in Optical Valley Branch of Tongji Hospital, Wuhan, China. This paper systematically summarizes the procedures of functional support therapies for multiple organs and systems, including respiratory, circulatory, renal, hepatic, and hematological systems, among patients with severe- and critical-type COVID-19. This paper provides a clinical reference and a new strategy for the optimal treatment of COVID-19 worldwide.

中文翻译：

---

2019年冠状病毒病患者的器官功能支持：同济经验。

冠状病毒病2019（COVID-19）是一种高度传染性疾病，对人类健康构成严重威胁。COVID-19可导致多种器官功能障碍，例如呼吸和循环衰竭，肝肾损伤，弥散性血管内凝血，血栓栓塞甚至死亡。世界卫生组织报告说，严重型COVID-19的死亡率超过50％。当前，世界范围内的严重病例数量迅速增加，但是治疗感染患者的经验仍然有限。由于缺乏特定的抗病毒药物，多器官功能支持治疗对COVID-19患者很重要。为了提高重症和危重型COVID-19患者的治愈率并降低其死亡率，本文总结了武汉同济医院光谷分院重症和危重型COVID-19患者器官功能支持的经验。本文系统地总结了重症和危重型COVID-19患者的多种器官和系统的功能支持疗法的程序，包括呼吸系统，循环系统，肾脏，肝脏和血液系统。本文为全球COVID-19的最佳治疗提供了临床参考和新策略。在严重和危重型COVID-19的患者中。本文为全球COVID-19的最佳治疗提供了临床参考和新策略。在严重和危重型COVID-19的患者中。本文为全球COVID-19的最佳治疗提供了临床参考和新策略。